JHMRI Logo

Johns Hopkins Malaria Research Institute

JHSPH Home

Email this page

Print this page

Search

Home

Research

People

News

Contact

Links

About Malaria

Faculty

David Sullivan, MD
David Sullivan, MD

My research program investigates new diagnostic tools, mechanism of drug action and epidemiology of drug resistance for P. falciparum.

Diagnosis-The laboratory is developing ELISA based HRP II and aldolase antigen testing to make quantitative determination of parasitemia in serum and urine. A hemozoin detection test by the method of mass spectroscopy is in development with Peter Scholl, Nirbhay Kumar and reseachers at JHU Applied Physics Lab.

Drug action- This area focuses on metal metabolism perturbed by antimalarial chemotherapy. We investigate the formation of iron rich hemozoin heme crystals and its inhibition by the quinolines. We are also investigating the the basic cell biology of iron, copper and zinc by characterization of genes for metal storage, transport and respective chaperones. We are developing mass spectroscopy for defining the metablolome (metabolites not encoded by the genome) to compare with the transcriptome in the investigation of drug effects on the parasite. Artemisinin also requires bioavailable iron for it mechanism of action to inhibit the calcium P-ATPASE pump. The laboratory is also screening a library of over 2,000 available FDA approved drugs for malaria inhibition.

Epidemiology of drug resistance- We are performing PCR based genotyping of drug resistance genes for chloroquine, antifolates, and mefloquine from fingerprick samples of blood on filter paper. In addition we are utilizing microsatellite allele determination in collaboration with Doug Norris for assessment of multiplicity of infection and duration of infection in longitudinal studies.

Placental Malaria- We are studying the interaction if HIV and malaria during pregnancy.

CONTACT DR. SULLIVANDavid Sullivan

Johns Hopkins University
Bloomberg School of Public Health
615 North Wolfe Street
Room E5628
Baltimore, MD 21205

email:    dsulliva@jhsph.edu
phone:   410-502-2522
fax:        410-955-0105

LINKS

JHSPH Faculty Page

SELECTED PUBLICATIONS

Jain SK, Persaud D, Perl TM, Pass MA, Murphy KM, Pisciotta JM, Scholl PF, Casella JF, Sullivan DJ.  Nosocomial malaria and saline flush.  Emerg Infect Dis 11:1097-1099, 2005. Article

Nyunt M, Pisciotta J, Feldman AB, Thuma P, Scholl PF, Demirev PA, Lin JS, Shi L, Kumar N, Sullivan DJ.  Detection of Plasmodium falciparum in pregnancy by laser desorption mass spectrometry.  Am J Trop Med Hyg 73:485-490, 2005. Article

Pisciotta JM, Ponder EL, Fried B, Sullivan D.  Hemozoin formation in Echinostoma trivolvis rediae.  Int J Parasitol 35:1037-1042, 2005.  Abstract

Rasoloson D, Shi L, Chong CR, Kafsack BF, Sullivan DJ. Copper pathways in Plasmodium falciparum infected erythrocytes indicate an efflux role for the copper P-ATPase. Biochem J 803-811, 2004. Article

Scholl PF, Kongkasuriyachai D, Demirev PA, Feldman AB, Lin JS, Sullivan DJ Jr, Kumar N. Rapid detection of malaria infection in vivo by laser desorption mass spectrometry. Am J Trop Med Hyg 71:546-551, 2004. Abstract

Brahmbhatt H, Kigozi G, Wabwire-Mangen F, Serwadda D, Sewakambo N, Lutalo T, Wawer M, Abramowsky C, Sullivan D, Gray R. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 17:2539-2541, 2003. Abstract

Chong C, Sullivan D. Inhibition of heme crystal growth by antimalarials and other compounds: implications for drug discovery. Biochem Pharm 66:2201-2212, 2003. Abstract

Iyer J, Shi L, Shankar A, Sullivan D. Zinc protoporphyrin IX binds heme crystals to inhibit the process of crystallization in Plasmodium falciparum. Mol Med 9:175-182, 2003. Abstract

Noland G, Briones N, Sullivan D. The shape and size of hemozoin crystals distinguishes diverse Plasmodium species. Mol Biochem Parasitol 130:91-99, 2003. Abstract

Akompong T, Kadekoppala M, Harrison T, Oksman A, Goldberg DE, Fujioka H, Samuel BU, Sullivan D, Haldar K. Trans-expression of a Plasmodium falciparum histidine-rich protein II (HRPII) reveals sorting of soluble proteins in the periphery of the host erythrocyte and disrupts transport to the malarial food vacuole. J Biol Chem 277:28923-28933, 2002. Article

Coban C, Ishii KJ, Sullivan DJ, Kumar N. Purified malaria pigment (hemozoin) enhances dendritic cell maturation and modulates the isotype of antibodies induced by a DNA vaccine. Inf Immun 70:3939-3943, 2002. Article

Demirev PA, Feldman AB, Kongkasuriyachai D, Scholl P, Sullivan D Jr, Kumar N. Detection of malaria parasites in blood by laser desorption mass spectrometry. Anal Chem 15;74:3262-3266, 2002. Abstract

Sullivan D. Theories on malarial pigment formation and quinoline action. Int J Parasitol 32:1645-1653, 2002. Abstract

Chen MM, Shi L, Sullivan DJ. Haemoproteus and Schistosoma synthesize heme polymers similar to Plasmodium hemozoin and beta-hematin. Mol Biochem Parasitol 113:1-8, 2001. Abstract

Hayward RE, Sullivan DJ, Day KP. Plasmodium falciparum: Histidine-rich protein II is expressed during gametocyte development. Exp Parasit 96:139-146, 2001. Abstract

© 2008, Johns Hopkins University. All rights reserved.
Web policies, 615 N. Wolfe Street, Baltimore, MD 21205,
410-955-6878

Johns Hopkins Bloomberg School of Public Health